| SOX2 |
ZHBTc4 (embryonic stem cells) |
control |
Permissive
Robust
|
Mus musculus |
GSE28453
...
|
MA0142.1
...
|
| SOX2 |
ZHBTc4 (embryonic stem cells) |
Tet |
Permissive
Robust
|
Mus musculus |
GSE28453
...
|
MA0142.1
...
|
| SOX2 |
ZHBTc4 (embryonic stem cells) |
Tet |
Permissive
Robust
|
Mus musculus |
GSE28453
...
|
MA0142.1
...
|
| SOX2 |
ZHBTc4 (embryonic stem cells) |
Tet |
Permissive
Robust
|
Mus musculus |
GSE28453
...
|
MA0142.1
...
|
| SOX2 |
ZHBTc4 (embryonic stem cells) |
Tet |
Permissive
Robust
|
Mus musculus |
GSE28453
...
|
MA0142.1
...
|
| SOX2 |
2TS22C (embryonic stem cells) |
Tet |
Permissive
|
Mus musculus |
GSE28453
...
|
MA0142.1
...
|
| SOX2 |
neuralized embryoid body |
all trans retinoic acid (RA) and SAG for 3 days before harvested |
Permissive
Robust
|
Mus musculus |
GSE42132
...
|
MA0142.1
...
|
| SOX2 |
embryonic stem cells |
none |
Permissive
Robust
|
Mus musculus |
GSE59378
...
|
MA0142.1
...
|
| SOX2 |
2TS22C (embryonic stem cells) |
O-GlcNAc-deficient SOX2, long fragments |
Permissive
Robust
|
Mus musculus |
GSE69592
...
|
MA0142.1
...
|
| SOX2 |
2TS22C (embryonic stem cells) |
O-GlcNAc-deficient SOX2, short fragments |
Permissive
Robust
|
Mus musculus |
GSE69592
...
|
MA0142.1
...
|
| SOX2 |
2TS22C (embryonic stem cells) |
long fragments |
Permissive
Robust
|
Mus musculus |
GSE69592
...
|
MA0142.1
...
|
| SOX2 |
2TS22C (embryonic stem cells) |
short fragments |
Permissive
Robust
|
Mus musculus |
GSE69592
...
|
MA0142.1
...
|
| SOX2 |
OKSM reprogrammed embryonic fibroblasts |
Chaf1a KO |
Permissive
Robust
|
Mus musculus |
GSE72744
...
|
MA0142.1
...
|
| SOX2 |
stomach |
SOX2 KO |
Permissive
Robust
|
Mus musculus |
GSE83965
...
|
MA0142.1
...
|
| SOX2 |
embryonic stem cells |
PARP-1 KO |
Permissive
Robust
|
Mus musculus |
GSE74112
...
|
MA0142.1
...
|
| SOX2 |
epiblast stem cells |
feeder free |
Permissive
Robust
|
Mus musculus |
GSE74636
...
|
MA0142.1
...
|
| SOX2 |
ZHBTc4 (embryonic stem cells) |
untreated control |
Permissive
Robust
|
Mus musculus |
GSE87820
...
|
MA0142.1
...
|
| SOX2 |
ZHBTc4 (embryonic stem cells) |
doxycycline-treated |
Permissive
Robust
|
Mus musculus |
GSE87820
...
|
MA0142.1
...
|
| SOX2 |
Brg1fl/fl (embryonic stem cells) |
untreated control |
Permissive
Robust
|
Mus musculus |
GSE87820
...
|
MA0142.1
...
|
| SOX2 |
Brg1fl/fl (embryonic stem cells) |
tamoxifen-treated |
Permissive
Robust
|
Mus musculus |
GSE87820
...
|
MA0142.1
...
|
| SOX2 |
E3.5 embryonic stem cells |
asynchronous cell cycle |
Permissive
Robust
|
Mus musculus |
GSE92846
...
|
MA0142.1
...
|
| SOX2 |
KH2 (embryonic stem cells) |
Overexpress Sox2-V5 tagged |
Permissive
Robust
|
Mus musculus |
GSE43275
...
|
MA0142.1
...
|
| SOX2 |
KH2 (embryonic stem cells) |
Overexpress Sox2KE-V5 tagged; Sox2KE variant |
Permissive
Robust
|
Mus musculus |
GSE43275
...
|
MA0142.1
...
|
| SOX2 |
MRC-5 (fetal lung fibroblasts) |
Treatment: Oct4, Sox2 and Klf4 addition for 5 days Passage: 8 |
Permissive
Robust
|
Homo sapiens |
GSE81899
...
|
MA0142.1
...
|
| SOX2 |
MRC-5 (fetal lung fibroblasts) |
Treatment: Oct4, Sox2-VP16 (strong activator) and Klf4 addition for 5 days Passage: 8 |
Permissive
Robust
|
Homo sapiens |
GSE81899
...
|
MA0142.1
...
|
| SOX2 |
MRC-5 (fetal lung fibroblasts) |
Genotype: wildtype Passage: 8 |
Permissive
|
Homo sapiens |
GSE81899
...
|
MA0142.1
...
|
| SOX2 |
MRC-5 (fetal lung fibroblasts) |
Treatment: Oct4, Sox2, Klf4 and Myc addition for 5 days Passage: 8 |
Permissive
Robust
|
Homo sapiens |
GSE81899
...
|
MA0142.1
...
|
| SOX2 |
MRC-5 (fetal lung fibroblasts) |
Treatment: Oct4, Sox2-VP16 (strong activator), Klf4 and Myc addition for 5 days Passage: 8 |
Permissive
Robust
|
Homo sapiens |
GSE81899
...
|
MA0142.1
...
|
| SOX2 |
iPS (derived pancreatic precursor cells) |
Treatment: iPS protocol 3s2 Passage: 20 |
Permissive
Robust
|
Homo sapiens |
GSE81899
...
|
MA0142.1
...
|
| SOX2 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP |
Permissive
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| SOX2 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, day3 MEF reprogramming intermediates |
Permissive
Robust
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| SOX2 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, day6 MEF reprogramming intermediates |
Permissive
Robust
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| SOX2 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, cKIT+, day9 MEF reprogramming intermediates |
Permissive
Robust
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| SOX2 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, sKIT+, day 12 MEF reprogramming intermediates |
Permissive
Robust
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| SOX2 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: GFP1+, MEF derived induced pluripotent stem cells |
Permissive
Robust
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| SOX2 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day3 cells refractory to MEF reprogramming. |
Permissive
Robust
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| SOX2 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day6 cells refractory to MEF reprogramming. |
Permissive
Robust
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| SOX2 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP |
Permissive
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| SOX2 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day3 cells refractory to MEF reprogramming. |
Permissive
Robust
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| SOX2 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, day3 MEF reprogramming intermediates |
Permissive
Robust
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| SOX2 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day6 cells refractory to MEF reprogramming. |
Permissive
Robust
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| SOX2 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, day6 MEF reprogramming intermediates |
Permissive
Robust
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| SOX2 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, cKIT+, day9 MEF reprogramming intermediates |
Permissive
Robust
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| SOX2 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, sKIT+, day 12 MEF reprogramming intermediates |
Permissive
Robust
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| SOX2 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: GFP1+, MEF derived induced pluripotent stem cells |
Permissive
Robust
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| SOX2 |
lung epithelial cells |
Strain: C57BL/6 Age: 8 week Genotype: wildtype |
Permissive
|
Mus musculus |
GSE108952
...
|
MA0142.1
...
|
| SOX2 |
lung epithelial cells |
Strain: C57BL/6 Age: 8 week Genotype: ectopic Sox2 expression and Nkx2-1 deletion |
Permissive
|
Mus musculus |
GSE108952
...
|
MA0142.1
...
|
| SOX2 |
lung epithelial cells |
Strain: C57BL/6 Age: 8 week Genotype: ectopic Sox2 expression |
Permissive
|
Mus musculus |
GSE108952
...
|
MA0142.1
...
|
| SOX2 |
ES-E14 (E14, embryonic stem cells) |
Uhrf1 KO |
Permissive
Robust
|
Mus musculus |
GSE113913
...
|
MA0142.1
...
|
| SOX2 |
Cell line generated from Lenti-Sox2-Cre infected KrasLSL-G12D/+;Trp53fl/fl (KPS) tumors |
Tissue: KPS1 cell line generated from Lenti-Sox2-Cre infected KrasLSL-G12D/+;Trp53fl/fl (KPS) tumors |
Permissive
|
Mus musculus |
GSE118244
...
|
MA0143.4
|
| SOX2 |
Cell line generated from Lenti-Sox2-Cre infected KrasLSL-G12D/+;Trp53fl/fl (KPS) tumors |
Tissue: KPS2 cell line generated from Lenti-Sox2-Cre infected KrasLSL-G12D/+;Trp53fl/fl (KPS) tumors |
Permissive
|
Mus musculus |
GSE118244
...
|
MA0142.1
...
|
| SOX2 |
Cell line generated from Lenti-Sox2-Cre infected KrasLSL-G12D/+;Trp53fl/fl (KPS) tumors |
Tissue: KPS3 cell line generated from Lenti-Sox2-Cre infected KrasLSL-G12D/+;Trp53fl/fl (KPS) tumors |
Permissive
|
Mus musculus |
GSE118244
...
|
MA0142.1
|
| SOX2 |
Lung squamous cell carcinoma from Lkb1fl/fl;Ptenfl/fl (LP) mouse model; infected with Ad5-CMV-Cre virus; harvested approximately 10 months post-infection. |
Tissue: Lung squamous cell carcinoma from Lkb1fl/fl;Ptenfl/fl (LP) mouse model |
Permissive
|
Mus musculus |
GSE118244
...
|
MA0142.1
...
|
| SOX2 |
cortex |
Sex: male Age: 1-2 months Strain: C57BL/6 Treatment: transduced with SOX2 |
Permissive
Robust
|
Mus musculus |
GSE85213
...
|
MA0142.1
...
|
| SOX2 |
embryonic fibroblasts |
Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shCtrl Passage: 1 Source: mouse embryonic fibroblast cells E13.5 |
Permissive
|
Mus musculus |
GSE99009
...
|
MA0142.1
...
|
| SOX2 |
embryonic fibroblasts |
Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shCtrl Passage: 1 Source: mouse embryonic fibroblast cells E13.5 |
Permissive
|
Mus musculus |
GSE99009
...
|
MA0142.1
...
|
| SOX2 |
embryonic fibroblasts |
Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shUbc9 Passage: 1 Source: mouse embryonic fibroblast cells E13.5 |
Permissive
|
Mus musculus |
GSE99009
...
|
MA0142.1
...
|
| SOX2 |
embryonic fibroblasts |
Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shUbc9 Passage: 1 Source: mouse embryonic fibroblast cells E13.5 |
Permissive
|
Mus musculus |
GSE99009
...
|
MA0142.1
...
|
| SOX2 |
Tg2a |
Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l |
Permissive
Robust
|
Mus musculus |
GSE122589
...
|
MA0142.1
...
|
| SOX2 |
Tg2a |
Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l |
Permissive
Robust
|
Mus musculus |
GSE122589
...
|
MA0142.1
...
|
| SOX2 |
Tg2a |
Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l |
Permissive
Robust
|
Mus musculus |
GSE122589
...
|
MA0142.1
...
|
| SOX2 |
Tg2a |
Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l |
Permissive
Robust
|
Mus musculus |
GSE122589
...
|
MA0142.1
...
|
| SOX2 |
Tg2a |
Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l |
Permissive
Robust
|
Mus musculus |
GSE122589
...
|
MA0142.1
...
|
| SOX2 |
Tg2a |
Cell type: ebryonic stem cells Treatment: FA Cell cecle: l |
Permissive
Robust
|
Mus musculus |
GSE122589
...
|
MA0142.1
...
|
| SOX2 |
Tg2a |
Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M |
Permissive
Robust
|
Mus musculus |
GSE122589
...
|
MA0142.1
...
|
| SOX2 |
Tg2a |
Cell type: ebryonic stem cells Treatment: FA Cellcycle: M |
Permissive
|
Mus musculus |
GSE122589
...
|
MA0142.1
...
|
| SOX2 |
Tg2a |
Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M |
Permissive
Robust
|
Mus musculus |
GSE122589
...
|
MA0142.1
...
|
| SOX2 |
differentiated embryonic stem cells |
Strain: C57BL/6N; |
Permissive
Robust
|
Mus musculus |
GSE93524
...
|
MA0142.1
...
|
| SOX2 |
squamous cell carcinoma |
Conditions: low calcium (50uM) conditions for 24 hrs; Strain: C57BL/6; Tissue: skin; |
Permissive
|
Mus musculus |
GSE104142
...
|
MA0142.1
...
|
| SOX2 |
squamous cell carcinoma |
Conditions: low calcium (50uM) conditions for 24 hrs; Strain: C57BL/6; Tissue: skin; |
Permissive
|
Mus musculus |
GSE104142
...
|
MA0142.1
...
|
| SOX2 |
E14TG2A (embryonic stem cells) |
Treatment: no Dox; Cell type: 44iN; Characteristic: lif +; |
Permissive
|
Mus musculus |
GSE118898
...
|
MA0142.1
...
|
| SOX2 |
E14TG2A (embryonic stem cells) |
Treatment: 1 ug/mL of Doxycycline; Cell type: 44iN; Characteristic: lif +; |
Permissive
Robust
|
Mus musculus |
GSE118898
...
|
MA0142.1
...
|
| SOX2 |
NIH 3T3 (embryonic fibroblasts) |
Genotype: Overexpression of SOX2; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding; |
Permissive
Robust
|
Mus musculus |
GSE119782
...
|
MA0142.1
...
|
| SOX2 |
hippocamus-derived neural progenitor cells |
Strain: mixed C57BL/6 x DBA; Source: hippocamus; |
Permissive
|
Mus musculus |
GSE90559
...
|
MA0142.1
...
|
| SOX2 |
hippocamus-derived neural progenitor cells |
Strain: mixed C57BL/6 x DBA; Source: hippocamus; |
Permissive
|
Mus musculus |
GSE90559
...
|
MA0142.1
...
|
| SOX2 |
BJ (fibroblasts) |
INDUCED |
Permissive
Robust
|
Homo sapiens |
GSE36570
|
MA0143.4
|
| SOX2 |
|
stem |
Permissive
Robust
|
Homo sapiens |
GSE67282
|
MA0143.4
|
| SOX2 |
embryonic stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE11724
...
|
MA0142.1
...
|
| SOX2 |
LN229 (glioblastoma) |
|
Permissive
|
Homo sapiens |
GSE23795
...
|
MA0142.1
...
|
| SOX2 |
embryonic stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE11431
...
|
MA0142.1
...
|
| SOX2 |
embryonic stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE44286
...
|
MA0142.1
...
|
| SOX2 |
embryonic stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE35496
...
|
MA0142.1
...
|
| SOX2 |
embryonic stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE35496
...
|
MA0142.1
...
|
| SOX2 |
neural progenitors |
|
Permissive
|
Mus musculus |
GSE35496
...
|
MA0142.1
...
|
| SOX2 |
embryonic stem cells |
|
Permissive
|
Mus musculus |
GSE35496
...
|
MA0142.1
...
|
| SOX2 |
neural progenitors |
|
Permissive
Robust
|
Mus musculus |
GSE35496
...
|
MA0142.1
...
|
| SOX2 |
embryonic stem cell-derived neural progenitors |
|
Permissive
Robust
|
Mus musculus |
GSE35496
...
|
MA0142.1
...
|
| SOX2 |
STHdhQ7 (striatal cells) |
|
Permissive
Robust
|
Mus musculus |
GSE43429
...
|
MA0142.1
...
|
| SOX2 |
HUES64 (embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE46130
...
|
MA0142.1
...
|
| SOX2 |
ZHBTc4-TS (trophoblast stem cells) |
|
Permissive
Robust
|
Mus musculus |
GSE51511
...
|
MA0142.1
...
|
| SOX2 |
EGFP-TS3.5 TS (trophoblast stem cells) |
|
Permissive
Robust
|
Mus musculus |
GSE51511
...
|
MA0142.1
...
|
| SOX2 |
D3 (embryonic stem cells) |
|
Permissive
Robust
|
Mus musculus |
GSE54103
...
|
MA0142.1
...
|
| SOX2 |
multipotent otic progenitors |
|
Permissive
Robust
|
Mus musculus |
GSE62513
...
|
MA0142.1
...
|
| SOX2 |
neural stem cells |
|
Permissive
|
Mus musculus |
GSE69859
...
|
MA0142.1
...
|
| SOX2 |
OKSM reprogrammed embryonic fibroblasts |
|
Permissive
Robust
|
Mus musculus |
GSE72744
...
|
MA0142.1
...
|
| SOX2 |
embryonic fibroblasts |
|
Permissive
Robust
|
Mus musculus |
GSE72744
...
|
MA0142.1
...
|
| SOX2 |
embryonic stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE74599
...
|
MA0142.1
...
|
| SOX2 |
stomach |
|
Permissive
Robust
|
Mus musculus |
GSE83965
...
|
MA0142.1
...
|
| SOX2 |
HUES64 (embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE61475
...
|
MA0142.1
...
|
| SOX2 |
HUES64 (embryonic stem cells) |
|
Permissive
|
Homo sapiens |
GSE61475
...
|
MA0142.1
...
|
| SOX2 |
HUES64 (embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE61475
...
|
MA0142.1
...
|
| SOX2 |
HUES64 (embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE61475
...
|
MA0142.1
...
|
| SOX2 |
embryonic stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE74112
...
|
MA0142.1
...
|
| SOX2 |
epiblast stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE74636
...
|
MA0142.1
...
|
| SOX2 |
WA09 (embryonic stem cells) |
|
Permissive
|
Homo sapiens |
GSE76082
...
|
MA0142.1
...
|
| SOX2 |
H9-derived neuroectoderm cells |
|
Permissive
|
Homo sapiens |
GSE76082
...
|
MA0142.1
...
|
| SOX2 |
ES-E14 (E14, embryonic stem cells) |
|
Permissive
Robust
|
Mus musculus |
GSE89599
...
|
MA0142.1
...
|
| SOX2 |
ES-E14 (E14, embryonic stem cells) |
|
Permissive
Robust
|
Mus musculus |
GSE89599
...
|
MA0142.1
...
|
| SOX2 |
ES-E14 (E14, embryonic stem cells) |
|
Permissive
Robust
|
Mus musculus |
GSE89599
...
|
MA0142.1
...
|
| SOX2 |
ES-E14 (E14, embryonic stem cells) |
|
Permissive
|
Mus musculus |
GSE89599
...
|
MA0142.1
...
|
| SOX2 |
embryonic fibroblasts expressing OSKM for 48h |
|
Permissive
Robust
|
Mus musculus |
GSE90893
...
|
MA0142.1
...
|
| SOX2 |
embryonic stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE90893
...
|
MA0142.1
...
|
| SOX2 |
embryonic fibroblasts expressing Sox2 from pMX vector for 48h |
|
Permissive
Robust
|
Mus musculus |
GSE90893
...
|
MA0142.1
...
|
| SOX2 |
embryonic fibroblasts expressing Sox2 from inducible system for 48h |
|
Permissive
Robust
|
Mus musculus |
GSE90893
...
|
MA0142.1
...
|
| SOX2 |
embryonic fibroblasts expressing Oct4,Sox2 from pMX vector for 48h |
|
Permissive
|
Mus musculus |
GSE90893
...
|
MA0142.1
...
|
| SOX2 |
embryonic fibroblasts expressing Oct4,Sox2,Klf4 from pMX vector for 48h |
|
Permissive
Robust
|
Mus musculus |
GSE90893
...
|
MA0142.1
...
|
| SOX2 |
pre-induced pluripotent stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE90893
...
|
MA0142.1
...
|
| SOX2 |
E3.5 embryonic stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE92846
...
|
MA0142.1
...
|
| SOX2 |
embryos, late blastula |
|
Permissive
Robust
|
Danio rerio |
GSE39780
...
|
MA0142.1
...
|
| SOX2 |
embryonic stem cell-derived neural progenitors |
|
Permissive
|
Mus musculus |
GSE33059
...
|
MA0142.1
...
|
| SOX2 |
ES-E14 (E14, embryonic stem cells) |
|
Permissive
Robust
|
Mus musculus |
GSE113913
...
|
MA0142.1
...
|
| SOX2 |
hESC-1 (Embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE18292
|
MA0143.4
|
| SOX2 |
H9 |
|
Permissive
Robust
|
Homo sapiens |
GSE46837
|
MA0143.4
|
| SOX2 |
KYSE70 (esophageal squamous carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE46837
|
MA0143.4
|
| SOX2 |
TT (hereditary thyroid gland medullary carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE46837
|
MA0143.4
|
| SOX2 |
hiPSC |
|
Permissive
Robust
|
Homo sapiens |
GSE56567
|
MA0143.4
|
| SOX2 |
hESC-1 (Embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE69479
|
MA0143.4
|
| SOX2 |
hNSC (neural stem cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE69479
|
MA0143.4
|
| SOX2 |
|
SHSOX2 |
Permissive
Robust
|
Homo sapiens |
GSE49404
|
MA0143.4
|
| SOX2 |
hiPSC |
INHI |
Permissive
Robust
|
Homo sapiens |
GSE67282
|
MA0143.4
|
| SOX2 |
hiPSC |
KDP53_INHI |
Permissive
Robust
|
Homo sapiens |
GSE67282
|
MA0143.4
|
| SOX2 |
|
|
Permissive
|
Homo sapiens |
GSE49404
|
MA0143.4
|
